company background image
RUA

RUA Life Sciences AIM:RUA Stock Report

Last Price

UK£0.54

Market Cap

UK£12.0m

7D

-10.7%

1Y

0.9%

Updated

06 Feb, 2023

Data

Company Financials +

RUA Stock Overview

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally.

RUA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

New

Notes are coming soon

RUA Life Sciences plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for RUA Life Sciences
Historical stock prices
Current Share PriceUK£0.54
52 Week HighUK£0.67
52 Week LowUK£0.31
Beta1.27
1 Month Change13.68%
3 Month Change56.52%
1 Year Change0.93%
3 Year Change-37.57%
5 Year Change14.89%
Change since IPO-96.10%

Recent News & Updates

Recent updates

The Rua Life Sciences (LON:RUA) Share Price Is Up 481% And Shareholders Are Delighted

Feb 15
The Rua Life Sciences (LON:RUA) Share Price Is Up 481% And Shareholders Are Delighted

Shareholder Returns

RUAGB Medical EquipmentGB Market
7D-10.7%3.9%0.8%
1Y0.9%-2.9%-4.6%

Return vs Industry: RUA exceeded the UK Medical Equipment industry which returned -4.8% over the past year.

Return vs Market: RUA exceeded the UK Market which returned -3.7% over the past year.

Price Volatility

Is RUA's price volatile compared to industry and market?
RUA volatility
RUA Average Weekly Movement14.5%
Medical Equipment Industry Average Movement8.3%
Market Average Movement5.1%
10% most volatile stocks in GB Market11.1%
10% least volatile stocks in GB Market2.7%

Stable Share Price: RUA is more volatile than 90% of UK stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: RUA's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
199638n/ahttps://rualifesciences.com

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves.

RUA Life Sciences plc Fundamentals Summary

How do RUA Life Sciences's earnings and revenue compare to its market cap?
RUA fundamental statistics
Market CapUK£11.98m
Earnings (TTM)-UK£1.90m
Revenue (TTM)UK£2.02m

5.9x

P/S Ratio

-6.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RUA income statement (TTM)
RevenueUK£2.02m
Cost of RevenueUK£316.00k
Gross ProfitUK£1.71m
Other ExpensesUK£3.60m
Earnings-UK£1.90m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.086
Gross Margin84.36%
Net Profit Margin-93.96%
Debt/Equity Ratio8.2%

How did RUA perform over the long term?

See historical performance and comparison